167 related articles for article (PubMed ID: 11799917)
1. Se-methylselenocysteine: a new compound for chemoprevention of breast cancer.
Medina D; Thompson H; Ganther H; Ip C
Nutr Cancer; 2001; 40(1):12-7. PubMed ID: 11799917
[TBL] [Abstract][Full Text] [Related]
2. Chemical form of selenium, critical metabolites, and cancer prevention.
Ip C; Hayes C; Budnick RM; Ganther HE
Cancer Res; 1991 Jan; 51(2):595-600. PubMed ID: 1824684
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of mammary cancer chemoprevention by organoselenium compounds.
El-Bayoumy K; Sinha R
Mutat Res; 2004 Jul; 551(1-2):181-97. PubMed ID: 15225592
[TBL] [Abstract][Full Text] [Related]
4. Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland.
Ip C; Thompson HJ; Ganther HE
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):49-54. PubMed ID: 10667463
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention.
Ip C; Thompson HJ; Zhu Z; Ganther HE
Cancer Res; 2000 Jun; 60(11):2882-6. PubMed ID: 10850432
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the biological activity of gamma-glutamyl-Se-methylselenocysteine: a novel, naturally occurring anticancer agent from garlic.
Dong Y; Lisk D; Block E; Ip C
Cancer Res; 2001 Apr; 61(7):2923-8. PubMed ID: 11306469
[TBL] [Abstract][Full Text] [Related]
7. Activities of structurally-related lipophilic selenium compounds as cancer chemopreventive agents.
Ip C; Lisk DJ; Ganther HE
Anticancer Res; 1998; 18(6A):4019-25. PubMed ID: 9891440
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention with triphenylselenonium chloride in selenium-deficient rats.
Ip C; Lisk DJ; Ganther HE
Anticancer Res; 2000; 20(6B):4179-82. PubMed ID: 11205245
[TBL] [Abstract][Full Text] [Related]
9. Elemental selenium at nano size (Nano-Se) as a potential chemopreventive agent with reduced risk of selenium toxicity: comparison with se-methylselenocysteine in mice.
Zhang J; Wang X; Xu T
Toxicol Sci; 2008 Jan; 101(1):22-31. PubMed ID: 17728283
[TBL] [Abstract][Full Text] [Related]
10. Cancer chemoprevention by aliphatic selenocyanates: effect of chain length on inhibition of mammary tumors and DMBA adducts.
Ip C; Vadhanavikit S; Ganther H
Carcinogenesis; 1995 Jan; 16(1):35-8. PubMed ID: 7834803
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of mammary cancer by diallyl selenide, a novel organoselenium compound.
el-Bayoumy K; Chae YH; Upadhyaya P; Ip C
Anticancer Res; 1996; 16(5A):2911-5. PubMed ID: 8917406
[TBL] [Abstract][Full Text] [Related]
12. Multiorgan sensitivity to anticarcinogenesis by the organoselenium 1,4-phenylenebis(methylene)selenocyanate.
el-Bayoumy K; Rao CV; Reddy BS
Nutr Cancer; 2001; 40(1):18-27. PubMed ID: 11799918
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity of various human tumour-derived cell types to apoptosis by organic derivatives of selenium.
Jariwalla RJ; Gangapurkar B; Nakamura D
Br J Nutr; 2009 Jan; 101(2):182-9. PubMed ID: 18549510
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine.
Unni E; Kittrell FS; Singh U; Sinha R
Breast Cancer Res; 2004; 6(5):R586-92. PubMed ID: 15318939
[TBL] [Abstract][Full Text] [Related]
15. Chemopreventive doses of methylselenocysteine alter circadian rhythm in rat mammary tissue.
Zhang X; Zarbl H
Cancer Prev Res (Phila); 2008 Jul; 1(2):119-27. PubMed ID: 19122877
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of mammary cancer with Se-allylselenocysteine and other selenoamino acids in the rat.
Ip C; Zhu Z; Thompson HJ; Lisk D; Ganther HE
Anticancer Res; 1999; 19(4B):2875-80. PubMed ID: 10652567
[TBL] [Abstract][Full Text] [Related]
17. Comparison of selenium and sulfur analogs in cancer prevention.
Ip C; Ganther HE
Carcinogenesis; 1992 Jul; 13(7):1167-70. PubMed ID: 1638682
[TBL] [Abstract][Full Text] [Related]
18. Methylselenocysteine modulates proliferation and apoptosis biomarkers in premalignant lesions of the rat mammary gland.
Ip C; Dong Y
Anticancer Res; 2001; 21(2A):863-7. PubMed ID: 11396176
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of organoselenium compounds for potential chemopreventive properties in colon cancer.
Reddy BS; Wynn TT; el-Bayoumy K; Upadhyaya P; Fiala E; Rao CV
Anticancer Res; 1996; 16(3A):1123-7. PubMed ID: 8702223
[TBL] [Abstract][Full Text] [Related]
20. Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitro.
Unni E; Koul D; Yung WK; Sinha R
Breast Cancer Res; 2005; 7(5):R699-707. PubMed ID: 16168115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
